MIS instrument market to grow at CAGR of 10.2% — 7 notes

The global minimally invasive surgical instrument market is anticipated to grow at a compound annual growth rate of 10.2 percent through 2021, based on a MarketsandMarkets report, according to HealthCareBusiness.

Advertisement

Here are seven notes:

 

1. The global MIS instrument market is expected to hit $18.14 billion by 2021.

 

2. In 2016, the market totals $11.16 billion.

 

3. An increasing geriatric population as well as a rising prevalence of bone conditions and spine injuries will spur the global market growth.

 

4. Private hospitals and surgical clinics captured the largest market share in 2015.

 

5. In 2015, North America dominated the global market.

 

6. The Asia Pacific region will experience the greatest market growth, due to an increasing demand for MIS instruments and companies entering in the market space.

 

7. Dominant market players include Medtronic, Ethicon, Aesculap, Stryker and Smith & Nephew.

 

More articles on devices:
Amendia, Benvenue Medical, Zimmer Biomet & more: 15 key notes
Amendia names Chris Fair CEO: 4 points
Trusting a robot — Dr. Juan Torres-Reveron on performing 1st US ROSA Spine surgery

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • Since March 25, there have been two key developments in lawsuits involving spine medtech companies. 1. The U.S. Court of…

  • The highest-paid CFOs at spine and orthopedic medtech companies saw total compensation reaching in the mid-single digits and beyond. Here…

Advertisement

Comments are closed.